Nfatc1tm1(cre)Bz/Nfatc1+ Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
|
abnormal aortic valve morphology |
J:226941
|
abnormal heart ventricle morphology |
J:226941
|
bicuspid aortic valve |
J:226941
|
cardiomyopathy |
J:226941
|
enlarged heart |
J:226941
|
normal
mortality/aging |
J:226941
|
thick aortic valve cusps |
J:226941
|
thick pulmonary valve |
J:226941
|
Nfatc1tm1.1(cre)Bz/Nfatc1+ Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
|
abnormal aortic sinus morphology |
J:226941
|
abnormal aortic valve cusp morphology |
J:226941
|
abnormal aortic valve morphology |
J:226941
|
abnormal cardiac outflow tract development |
J:226941
|
abnormal coronary artery morphology |
J:226941
|
abnormal coronary vein morphology |
J:226941
|
abnormal pulmonary valve cusp morphology |
J:226941
|
abnormal semilunar valve morphology |
J:226941
|
bicuspid aortic valve |
J:226941
|
enlarged heart |
J:226941
|
lethality throughout fetal growth and development, incomplete penetrance |
J:226941
|
perimembraneous ventricular septal defect |
J:226941
|
perinatal lethality |
J:226941
|
thick aortic valve |
J:226941
|
thick heart valve cusps |
J:226941
|
thick myocardium |
J:226941
|
thick pulmonary valve |
J:226941
|
Smarca4b2b508.1Clo/Smarca4b2b508.1Clo
C57BL/6J-Smarca4b2b508.1Clo
|
anophthalmia |
J:175213
|
atrioventricular septal defect |
J:175213
|
complete atrioventricular septal defect |
J:175213
|
double outlet right ventricle |
J:175213
|
microcephaly |
J:175213
|
micrognathia |
J:175213
|
ventricular septal defect |
J:175213
|
Smarca4b2b692Clo/Smarca4b2b692Clo
C57BL/6J-Smarca4b2b692Clo
|
coronary-cameral fistula to heart right ventricle |
J:175213
|
double outlet right ventricle |
J:175213
|
muscular ventricular septal defect |
J:175213
|
overriding aortic valve |
J:175213
|
perimembraneous ventricular septal defect |
J:175213
|
Smarca4enu1/Smarca4tm1Mag
involves: 129S/Sv * C57BL/10 * CBA/Cbi
|
abnormal blood cell morphology/development |
J:103896
|
abnormal erythrocyte morphology |
J:103896
|
abnormal liver morphology |
J:103896
|
embryonic lethality during organogenesis, complete penetrance |
J:103896
|
Smarca4mos6/Smarca4mos6
involves: BALB/cJ * C57BL/6J
|
embryonic lethality, complete penetrance |
J:241206
|
Smarca4tm1.1Axvi/Smarca4tm1.1Axvi
involves: 129S6/SvEvTac
|
no abnormal phenotype detected |
J:212226
|
Smarca4tm1.1Grc/Smarca4tm1.1Grc
involves: 129 * C57BL/6
|
no abnormal phenotype detected |
J:101977
|
Smarca4tm1.1Pcn/Smarca4+
involves: 129S2/SvPas * C57BL/6 * DBA/2
|
cyanosis |
J:172661
|
patent ductus arteriosus |
J:172661
|
ventricular septal defect |
J:172661
|
Smarca4tm1.2Pcn/Smarca4tm1.1Pcn Tg(Myh11-cre,-EGFP)2Mik/0
involves: 129S2/SvPas * C57BL/6 * DBA/2
|
abnormal intestinal smooth muscle morphology |
J:172661
|
abnormal jejunum morphology |
J:172661
|
abnormal muscle physiology |
J:172661
|
abnormal pulmonary circulation |
J:172661
|
abnormal small intestine morphology |
J:172661
|
congestive heart failure |
J:172661
|
cyanosis |
J:172661
|
decreased colon length |
J:172661
|
decreased small intestine length |
J:172661
|
dilated heart |
J:172661
|
enlarged cecum |
J:172661
|
enlarged ileum |
J:172661
|
impaired smooth muscle contractility |
J:172661
|
megacolon |
J:172661
|
patent ductus arteriosus |
J:172661
|
postnatal lethality, incomplete penetrance |
J:172661
|
primary atelectasis |
J:172661
|
pulmonary alveolar proteinosis |
J:172661
|
ventricular septal defect |
J:172661
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn Tg(KRT14-cre)1Ipc/?
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal apical ectodermal ridge morphology |
J:101729
|
abnormal digit morphology |
J:101729
|
abnormal epidermis stratum corneum morphology |
J:101729
|
abnormal hindlimb morphology |
J:101729
|
abnormal hindlimb zeugopod morphology |
J:101729
|
abnormal skin morphology |
J:101729
|
dry skin |
J:101729
|
impaired skin barrier function |
J:101729
|
monodactyly |
J:101729
|
neonatal lethality, complete penetrance |
J:101729
|
shiny skin |
J:101729
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn Tg(KRT14-cre/ERT2)1Ipc/?
involves: 129S2/SvPas
|
abnormal digit morphology |
J:101729
|
abnormal epidermis stratum corneum morphology |
J:101729
|
abnormal hindlimb morphology |
J:101729
|
abnormal skin morphology |
J:101729
|
impaired skin barrier function |
J:101729
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn Tg(Lck-cre)1Cwi/0
Not Specified
|
abnormal T cell morphology |
J:144072
|
decreased double-negative T cell number |
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn Tg(Nfat1c-cre)1Bz/0
involves: 129S2/SvPas
|
normal
cardiovascular system phenotype |
J:226941
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn Tg(Sox10-cre)1Wdr/0
involves: 129S2/SvPas * C57BL/6 * CBA
|
abnormal melanoblast morphology |
J:241206
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn Tg(Tek-cre)1Ywa/0
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal atrioventricular cushion morphology |
J:226941
|
abnormal cardiac outflow tract development |
J:226941
|
Smarca4tm1.2Pcn/Smarca4tm1Mag Tg(Lck-cre)1Cwi/?
involves: 129S/Sv * C57BL/6 * DBA/2
|
abnormal T cell differentiation |
J:85191
|
absent CD8-positive, alpha-beta T cells |
J:85191
|
arrested T cell differentiation |
J:85191
|
decreased CD4-positive, alpha-beta T cell number |
J:85191
|
decreased double-negative T cell number |
J:85191
|
decreased double-positive T cell number |
J:85191
|
thymus hypoplasia |
J:85191
|
Smarca4tm1.2Pcn/Smarca4tm1Tich Tg(Lck-cre)1Cwi/0
involves: 129
|
abnormal T cell morphology |
J:144072
|
decreased double-negative T cell number |
J:144072
|
decreased thymocyte number |
J:144072
|
Smarca4tm1Mag/Smarca4+
involves: 129S/Sv * C57BL/6J * CD-1
|
increased mammary adenocarcinoma incidence |
J:132091
|
increased osteosarcoma incidence |
J:132091
|
Smarca4tm1Mag/Smarca4+
involves: 129S/Sv * CD-1
|
decreased survivor rate |
J:66861
|
exencephaly |
J:66861
|
increased tumor incidence |
J:66861
|
postnatal lethality, incomplete penetrance |
J:66861
|
Smarca4tm1Mag/Smarca4tm1.2Pcn
involves: 129S2/SvPas
|
normal
cellular phenotype |
J:66861
|
Smarca4tm1Mag/Smarca4tm1Mag
involves: 129S/Sv * CD-1
|
embryonic lethality before implantation, complete penetrance |
J:66861
|
Smarca4tm1Tich/Smarca4+
involves: 129
|
normal
immune system phenotype |
J:144072
|
Smarca4tm1Tich/Smarca4+ Tg(Lck-cre)1Cwi/0
involves: 129
|
decreased double-negative T cell number |
J:144072
|
decreased double-positive T cell number |
J:144072
|
decreased single-positive T cell number |
J:144072
|
decreased thymocyte number |
J:144072
|